Miguel Angel Valdes-sueiras is a Sylmar, California based neurologist who is specialized in Neurology. Active license number of Miguel Angel Valdes-sueiras is A64933 for Neurology in California. His current practice location is 14445 Olive View Dr, #2c-136, Sylmar. Patients can reach him at 818-364-3104. Miguel Angel Valdes-sueiras is MD in Neurology and his NPI number (Unique professional ID assigned by NPPES) is 1598758864. Miguel Angel Valdes-sueiras specializes in the diagnosis and treatment of diseases or impaired function of the brain, spinal cord, peripheral nerves, muscles, autonomic nervous system, and blood vessels that relate to these structures.
Complete Profile:
Miguel Angel Valdes-sueiras speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1598758864
NPI Enumeration Date:
23 Aug, 2005
NPI Last Update On:
23 Apr, 2015
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Miguel Angel Valdes-sueiras are as mentioned below.
License Number
Specialization
State
Status
A64933
Neurology
California
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Miguel Angel Valdes-sueiras 14445 Olive View Dr, 2c-136 Sylmar, California
Zip:
91342-1437
Phone Number:
818-364-3104
Patients can reach Miguel Angel Valdes-sueiras at 14445 Olive View Dr, #2c-136, Sylmar, California or can call to book an appointment on 818-364-3104.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.